ending plague a scholar's obligation in an age of corruption

Kent Heckenlively, JD, is a former attorney, a founding editor of Age of Autism, and a science teacher. Mikovits lives in Southern California with her husband, David. She co-founded and directed the first neuroimmune disease institute using a systems biology approach in 2006. Ruscetti, one of the founding fathers of human retrovirology, and has coauthored more than forty scientific papers. Mikovits spent twenty years at the National Cancer Institute, working with Dr. Since his retirement, he has been consulting with patients and their families, continuing his lifelong effort to understand the process of chronic disease development and develop therapeutic treatment strategies. Ruscetti retired in 2014, with more than 325 publications. After thirty-nine years at the National Cancer Institute, Dr. In 2009, they identified a new family of retroviruses, the XMRVs from patients with chronic fatigue syndrome (ME/CFS). Mikovits work on understanding the contribution of inflammatory pathways in disease, specifically how retroviruses dysregulate DNA methylation. In order to develop new antiviral drugs, Ruscetti and Dr. Ruscetti received the ＂Distinguished Service Award＂ from the National Institutes of Health.

Similarly, the HTLV-1 manuscript was cited as one of the thirty most important papers in the hundred years of the publication in Proceedings of the National Academy of Science. In 2013, the IL-2 manuscript was recognized by the American Association of Immunologists as the second most important paper published in their Journal in the past hundred years. These discoveries have all been the basis for the development of useful therapeutics. In hematology, his team demonstrated that human cord blood cells proliferate continuously in vitro and TGF Beta functions as a bidirectional regulator of the hematopoietic stem cell. During the 1980s, his team identified IL-15, an additional immune response regulator. In 1980, the team he directed at the NCI isolated the first known disease-causing human retrovirus, HTLV-1, opening the field of human retrovirology, which would rise to critical importance during the HIV-AIDS epidemic. Ruscetti’s team discovered interleukin 2 (T-Cell Growth factor), for which they won a team award from the Society for Immunotherapy of Cancer. In 1978 at National Cancer Institute (NCI), Dr. In 1975, while a fellow at University of Pittsburgh, he discovered Interleukin-5. Ruscetti, PhD has had a lifelong love affair with scientific discovery and participated in several seminal discoveries.

Ending plague a scholar's obligation in an age of corruption